GKOS
Glaukos Corporation
Glaukos Corporation (GKOS) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 71.0 (overbought), with 3/3 trend checks passing.
GKOS with MA50 and MA200
Key levels & signals
Glaukos Corporation (GKOS) is still trading in a constructive trend overall. The latest available price is $156.84, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 17.4% and above the 200-day moving average by 39.0%.
GKOS currently has an RSI reading of 71.0, which suggests stronger momentum and a more stretched short-term backdrop. Trend traders may still find that attractive, while more patient traders may prefer to wait and see whether the stock cools off first.
For traders reviewing GKOS next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.
About Glaukos Corporation
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Learn the indicators behind this page
More stock opportunities
Common questions about GKOS
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.